Literature DB >> 1082346

Human leukocyte granule elastase: rapid isolation and characterization.

R J Baugh, J Travis.   

Abstract

Human granulocytic elastases have been purified by a two-step procedure involving affinity chromatography of crude extracts of leukocytic granules on Sepharose-Trasylol, followed by ion-exchange chromatography on CM-cellulose to resolve the isoelastases. All of these enzymes were found to be glycoproteins with the carbohydrate content of the major form being composed essentially of only neutral sugars. The molecular weight of this form was found to be near 30 000 daltons with the other forms being slightly higher. Preliminary structural analyses indicate that all of the elastase isozymes have identical NH2-terminal sequences suggesting that the differences in mobility of the four proteins are not due to different degrees of activation from a common zymogen but, more likely, from minor changes in carbohydrate content. Human granulocytic elastases are less active on ligament elastin than porcine pancreatic elastase, but both are inhibited by synthetic elastase active-site directed low molecular weight compounds (Tuhy, P. M., and Powers, J. C. (1975), FEBS Lett. 50, 359) as well as by plasma alpha-1-proteinase inhibitor (formerly called alpha-1-antitrypsin). In the latter case a stable complex with mol wt of 78 000 daltons is formed indicating the formation of a 1:1 complex.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082346     DOI: 10.1021/bi00649a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  106 in total

1.  Inactivation of human thrombin in the presence of human alpha1-proteinase inhibitor.

Authors:  N R Matheson; J Travis
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

2.  Comparative properties of three functionally different but structurally related serpin variants from horse plasma.

Authors:  J Potempa; J K Wunderlich; J Travis
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.

Authors:  D H Perlmutter; J Travis; P I Punsal
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

4.  A segment of gamma ENaC mediates elastase activation of Na+ transport.

Authors:  Adedotun Adebamiro; Yi Cheng; U Subrahmanyeswara Rao; Henry Danahay; Robert J Bridges
Journal:  J Gen Physiol       Date:  2007-11-12       Impact factor: 4.086

5.  Cathepsin G and thrombin: evidence for two different platelet receptors.

Authors:  M A Selak
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic, and biochemical effects on hamster lungs in vitro.

Authors:  S A Lonky; H Wohl
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.

Authors:  Katarzyna Zabieglo; Pawel Majewski; Monika Majchrzak-Gorecka; Agnieszka Wlodarczyk; Beata Grygier; Aneta Zegar; Monika Kapinska-Mrowiecka; Antonina Naskalska; Krzysztof Pyrc; Adam Dubin; Sharon M Wahl; Joanna Cichy
Journal:  J Leukoc Biol       Date:  2015-04-27       Impact factor: 4.962

9.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

10.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.